Lack of influence ofDAT1andDRD2gene variants on antidepressant response in generalized anxiety disorder-Reference-Cited by-同舟云学术

Lack of influence ofDAT1andDRD2gene variants on antidepressant response in generalized anxiety disorder

Published:2014-04-10 Issue:4 Volume:29 Page:316-321
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol Clin Exp

Author:

Saung Wint Thu¹,Narasimhan Sneha¹,Lohoff Falk W.¹²

Affiliation:

1. Psychiatric Pharmacogenetics Laboratory, Center for Neurobiology and Behavior, Department of Psychiatry; University of Pennsylvania School of Medicine; Philadelphia PA USA

2. Mood and Anxiety Disorders Section, Department of Psychiatry; University of Pennsylvania School of Medicine; Philadelphia PA USA

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hup.2404/fullpdf

Reference27 articles.

1. Erotomania induced by venlafaxine: a case study;Adamou;Acta Psychiatr Scand,2003

2. Effect of venlafaxine and nicotine on the level of neurotransmitters and their metabolites in rat brains;Czubak;J Physiol Pharmacol,2010

3. A common haplotype at the dopamine transporter gene 5' region is associated with attention-deficit/hyperactivity disorder;Genro;Am J Med Genet B Neuropsychiatr Genet,2008

4. Second-generation antipsychotics in the treatment of major depressive disorder: current evidence;Han;Expert Rev Neurother,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early life stress and the role of environmental and molecular moderators in the ontology of pathological and resilient behavioral phenotypes;Molecular Psychology: Brain, Behavior, and Society;2023-09-26

2. Early life stress and the role of environmental and molecular moderators in the ontology of pathological and resilient behavioral phenotypes;Molecular Psychology: Brain, Behavior, and Society;2022-11-04

3. The role of pharmacogenetics in the treatment of anxiety disorders and the future potential for targeted therapeutics;Expert Opinion on Drug Metabolism & Toxicology;2021-10-15

4. Pharmacogenetics of anxiety disorders;Neuroscience Letters;2020-05

5. Personalized Clinical Approaches to Anxiety Disorders;Advances in Experimental Medicine and Biology;2020